4//SEC Filing
Nokes Rachael 4
Accession 0000899243-23-002425
CIK 0001604950other
Filed
Jan 22, 7:00 PM ET
Accepted
Jan 23, 5:54 PM ET
Size
10.8 KB
Accession
0000899243-23-002425
Insider Transaction Report
Form 4
Nokes Rachael
CFO and Treasurer
Transactions
- Tax Payment
Common Stock
2020-02-25$10.09/sh−1,981$19,988→ 11,869 total - Tax Payment
Common Stock
2021-02-25$7.27/sh−1,976$14,366→ 9,893 total - Award
Stock Option (right to buy)
2023-01-19+17,550→ 17,550 totalExercise: $6.14Exp: 2033-01-19→ Common Stock (17,550 underlying) - Award
Common Stock
2023-01-19$6.14/sh+11,700$71,838→ 21,593 total
Footnotes (3)
- [F1]The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to the vesting of restricted stock units.
- [F2]Consists of a restricted stock unit ("RSU") award made pursuant to the ScPharmaceuticals Inc. 2017 Stock Option and Incentive Plan. The RSUs vest as to 25% of the shares underlying the RSUs on each of the first four anniversaries of January 1, 2023, such that the RSUs will be fully vested on January 1, 2027.
- [F3]The option shares vest over a four-year period, at a rate of 25% on January 1, 2024, with the remaining option shares vesting in 36 equal monthly installments thereafter, such that the option shares will be fully vested on January 1, 2027.
Documents
Issuer
scPharmaceuticals Inc.
CIK 0001604950
Entity typeother
Related Parties
1- filerCIK 0001769138
Filing Metadata
- Form type
- 4
- Filed
- Jan 22, 7:00 PM ET
- Accepted
- Jan 23, 5:54 PM ET
- Size
- 10.8 KB